Evidence map›Paper›PMID 35542913›Full record

ArticleRSC advances2018

Eugenol triggers CD11b

Ying Ding, Zecheng Yang, Wensheng Zhang, Yuwei Xu, Yuanyuan Wang, Minghua Hu, Fangli Ma, Hanan Long, Ning Tao, Zhihai Qin

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Ying DingSchool of Basic Medical Sciences of Southwest Medical University Luzhou China.ORCID https://orcid.org/0000-0002-7791-1908
Zecheng YangCollege of Life Science, University of the Chinese Academy of Sciences Beijing China.
Wensheng ZhangDepartment of Microbiology and Immunology, Shanxi Medical University Taiyuan China.ORCID https://orcid.org/0000-0001-7649-4180
Yuwei XuCollege of Life Science, University of the Chinese Academy of Sciences Beijing China.ORCID https://orcid.org/0000-0002-6477-2857
Yuanyuan WangInfinitus Chinese Herbal Immunity Research Centre, Infinitus China Company Ltd Guangzhou China.ORCID https://orcid.org/0000-0002-7596-7406
Minghua HuInfinitus Chinese Herbal Immunity Research Centre, Infinitus China Company Ltd Guangzhou China.ORCID https://orcid.org/0000-0002-1389-7369
Fangli MaInfinitus Chinese Herbal Immunity Research Centre, Infinitus China Company Ltd Guangzhou China.ORCID https://orcid.org/0000-0002-3243-3973
Hanan LongDepartment of Pathology, The Affiliated Hospital of Southwest Medical University Luzhou Sichuan China longhanan@swmu.edu.cn.
Ning TaoKey Laboratory of Protein and Peptide Pharmaceuticals, Institute of Biophysics, Chinese Academy of Sciences Datun Road No. 15 Chaoyang District Beijing China tao@ibp.ac.cn zhihai@ibp.ac.cn.ORCID https://orcid.org/0000-0002-0021-4995
Zhihai QinSchool of Basic Medical Sciences of Southwest Medical University Luzhou China.ORCID https://orcid.org/0000-0001-9793-7964
Infinitus (China) · CNChinese Academy of Sciences · CNSouthwest Medical University · CNUniversity of Chinese Academy of Sciences · CNShanxi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To study the effect and underlying molecular mechanism of eugenol on CD11b

Identifiers

PMID35542913
PMCPMC9077712
OpenAlexW2782824692

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.